EUVIMEDDescubrir EUVIMED
CrossrefTarjeta informativa

Gut microbiota and adolescent depression

Mariya A. Omelchenko, Leila R. Akhmadeeva, Vasilii O. Generalov, Marsel M. Tuygunov

Science and Innovations in Medicine · 2026-10-06 · 11 (4) · 282-286

DOI: 10.35693/sim706808 ↗
ResumenDatos bibliográficos

Resumen

This paper dwells on the connection between gut microbiota and depression in adolescents, along with a case report of a 15-year-old patient with a mild depressive episode who was treated primarily by targeting the gut microbiota. This therapeutic approach is pathogenetically justified by the specific nature of adolescent depression, in which the elevated reactivity of the limbic system plays a significant role. Given the limbic system’s high sensitivity to signals from the hypothalamic-pituitary-adrenal (HPA) axis, reducing HPA axis hyperactivity is a key component of therapy. The most accessible target for mitigating the negative impact of stress on HPA axis function, within the “microbiota-gut-brain” axis, is the initial link in the chain: the microbiota itself. Consequently, the use of probiotic agents, which offer both a favorable safety profile and proven efficacy, holds promise for the treatment and prevention of adolescent depression.

Conocimiento que se adapta a su trabajo.

Desde un inicio gratuito y la búsqueda bibliográfica personal hasta la Research Suite completa.

Ver tarifas →

¿Se incluyen todos los textos completos editoriales?

No. Registros, resúmenes y textos completos son contenidos diferentes. La disponibilidad depende de la fuente, del acceso abierto y de sus licencias. Un plan EUVIMED no sustituye derechos editoriales adicionales.

Ver tarifas →